Search

everythinglearnresearchcommunity

for

Search:↓

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Early intervention with JAK inhibitors may prevent alopecia areata progression.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

A specific enzyme is essential for proper hair follicle stem cell development and healthy skin.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

Clonally expanded CD8+ T cells cause alopecia areata.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Higher CD8+ T cell levels are linked to Alopecia areata in Iraqi patients.

Foxp3+ Regulatory T Cells are important for immunity and tolerance, affect hair growth and wound healing, and their dysfunction can contribute to obesity-related diseases and other health issues.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

Psoriasis involves an imbalance between certain immune cells, and targeting these could help restore skin health.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Targeting regulatory T cells may help treat age-related diseases.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

Astrotactin2 affects hair follicle orientation and skin cell polarity.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Regulatory T cells help heal skin and grow hair, and their absence can lead to healing issues and hair loss.

Regulatory T cells help hair growth by using the Cxcr4-Cxcl12 pathway.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

γδ T cells are essential for wound healing after poxvirus infection.